XML 90 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Shareholders’ Equity - USD ($)
Preferred Stock
Series A
Common Stock
Additional Paid-In Capital
[1]
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total Shareholders’ Equity (Deficit) Attributable to 60P
Noncontrolling Interest on Shareholders
Total
Balance at Dec. 31, 2022 $ 4 [1] $ 5,164,696 $ (28,815,148) $ 73,708 $ (23,576,740) $ (572,320) $ (24,149,060)
Balance (in Shares) at Dec. 31, 2022 39,768 [1]            
Voluntary conversion of Series A Preferred Stock into common stock $ (270,460) [1] 270,460
Voluntary conversion of Series A Preferred Stock into common stock (in Shares) (2,162) 760 [1]            
Share-based compensation under 2022 Equity Incentive Plan [1] 528,926 528,926 528,926
Share-based compensation under 2022 Equity Incentive Plan (in Shares) [1]   668            
Contribution from noncontrolling interest [1] (548,380) (548,380) 548,380
Deemed capital contribution for related party compensation expense (Note 11)     163,228 163,228   163,228
Cancellation of common stock $ (2) [1] 2
Cancellation of common stock (in Shares) [1]   (24,186)            
Share-based compensation to vendors for services $ 3 [1] 5,683,053 5,683,056 5,683,056
Share-based compensation to vendors for services (in Shares) [1]   24,717            
Conversion of debt into common stock upon initial public offering $ 3 [1] 7,989,595 7,989,598 7,989,598
Conversion of debt into common stock upon initial public offering (in Shares) [1]   28,460            
Conversion of debt into Series A Preferred Stock upon initial public offering $ 10,128,500 [1] 10,128,500 10,128,500
Conversion of debt into Series A Preferred Stock upon initial public offering (in Shares) 80,965              
Reclassification of liability-classified warrants to equity-classified [1] 838,748 838,748 838,748
Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740 $ 2 [1] 6,235,274 6,235,276 6,235,276
Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740 (in Shares) [1]   23,585            
Issuance of common stock upon exercise of warrants [1] 1,131,771 1,131,771 1,131,771
Issuance of common stock upon exercise of warrants (in Shares) [1]   3,075            
Share-based compensation expense               119,246
Net foreign translation gain (loss) [1] 61,853 61,853 61,853
Net income (loss) [1] (3,765,702) (3,765,702) (48,098) (3,813,800)
Balance at Dec. 31, 2023 $ 9,858,040 $ 10 [1] 27,457,373 (32,580,850) 135,561 4,870,134 (72,038) 4,798,096
Balance (in Shares) at Dec. 31, 2023 78,803 96,847 [1]            
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs $ 9 [1] 1,898,287 1,898,296 1,898,296
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (in Shares) [1]   87,683            
Issuance of common stock upon exercise of Pre-Funded Warrants $ 21 [1] 10,942 10,963 10,963
Issuance of common stock upon exercise of Pre-Funded Warrants (in Shares) [1]   211,163            
Issuance of shares for RSUs [1]
Issuance of shares for RSUs (in Shares) [1]   4,270            
Voluntary return of shares issued to vendor for services [1]
Voluntary return of shares issued to vendor for services (in Shares) [1]   (2,000)            
Voluntary conversion of Series A Preferred Stock into common stock $ (290,601) $ 1 [1] 290,600
Voluntary conversion of Series A Preferred Stock into common stock (in Shares) (2,323) 14,667 [1]            
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 $ 14 [1] 1,729,796 1,729,810 1,729,810
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 (in Shares) [1]   135,568            
Issuance of warrants in Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600 [1] 3,414,502 3,414,502 3,414,502
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment $ 2 [1] (2)  
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment (in Shares) [1]   18,710            
Share-based compensation to vendors for services [1] 26,325 26,325 26,325
Share-based compensation expense [1] 32,767 32,767 32,767
Net foreign translation gain (loss) [1] (90) (90) (90)
Net income (loss) [1] (7,947,107) (7,947,107) (8,556) (7,955,663)
Balance at Dec. 31, 2024 $ 9,567,439 $ 57 [1] $ 34,860,590 $ (40,527,957) $ 135,471 $ 4,035,600 $ (80,594) $ 3,955,006
Balance (in Shares) at Dec. 31, 2024 76,480 566,908 [1]            
[1] Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024 and the 1:5 reverse stock split on February 24, 2025.